GlassScriptPhysician profile
Onyx Haran
NPI 1740942317
$2,962.67
in general payments reported to CMS, 2019-2025
16 companies · $727 in 2025
The $727 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $576 · 2023: $231 · 2024: $1,429 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,307 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,306.93 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $541.66 | 2022-2025 | |
| Janssen Biotech, INC. | $488.47 | 2024-2025 | Tremfya |
| Dermavant Sciences, INC. | $461.07 | 2023-2024 | Vtama |
| Genzyme Corporation | $354.71 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $295.07 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $161.18 | 2022-2025 | Dupixent, Libtayo |
| Organon LLC | $160.52 | 2025 | Vtama |
| Pfizer INC. | $124.09 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $73.50 | 2022-2024 | |
| Galderma Laboratories, L.P. | $68.87 | 2025 | Nemluvio |
| Amgen INC. | $53.57 | 2024-2025 | Otezla, Otezla |
| Incyte Corporation | $50.75 | 2022-2024 | Opzelura |
| Ucb, INC. | $47.79 | 2024-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $46.83 | 2023 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $18.75 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $15.84 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Onyx Haran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.